佛慈制藥(002644.SZ)取得新營業執照 新增經營範圍涉及醫療器械、口罩及防護服
格隆匯3月5日丨佛慈制藥(002644.SZ)公佈,公司於2020年2月21日召開2020年第二次臨時股東大會,審議通過了《關於增加經營範圍暨修訂<公司章程>的議案》,同意增加公司經營範圍:“醫療器械的研發、生產及銷售;口罩、防護服等生產和銷售”,並對《公司章程》進行相應修訂。
近日,公司已完成了工商變更登記手續並取得了新的《營業執照》,公司經營範圍變更為:中成藥、西藥、中藥飲片(生產地址及範圍詳見藥品生產許可證)及包裝品的生產、批發零售;中藥材種植、收購、加工、銷售;自有資產投資、租賃、轉讓、收益;利用自有顯示屏發佈自產藥品廣告;自營和代理各類商品和技術進出口(國家限制和禁止的項目除外);熱力生產和供應;醫療器械的研發、生產及銷售;口罩、防護服的生產和銷售。(依法須經批准的項目,經有關部門批准後方可經營)其餘登記事項不變。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.